CUV 0.85% $14.16 clinuvel pharmaceuticals limited

Wolgen explained how it would not be looked upon favorably with...

  1. 1,247 Posts.
    lightbulb Created with Sketch. 185
    Wolgen explained how it would not be looked upon favorably with payors (governments, insurers etc) if the company used funds to perform a buy-back, it would signal they are making excessive returns and could jeopardize reimbursement agreements.'

    Complete and utter, contemptible, bollocks from Wolgen. Again.

    Fundamentally unjustifiable statement he fabricated from his backside.

    Again, a capable CEO who has been there far too long!
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.16
Change
0.120(0.85%)
Mkt cap ! $709.1M
Open High Low Value Volume
$13.98 $14.42 $13.95 $1.375M 96.72K

Buyers (Bids)

No. Vol. Price($)
1 106 $14.11
 

Sellers (Offers)

Price($) Vol. No.
$14.25 800 1
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.